FDA issues quarterly list of drugs under safety investigation

10/7/2009 | Reuters

The FDA released its quarterly list of drugs under review for potential safety issues. Included are Pfizer's cancer treatment Sutent, Wyeth and Progenics Pharmaceuticals' constipation drug Relistor, and Medicis Pharmaceutical's antibiotic Solodyn. The agency reiterated that appearance on the list "does not mean that FDA has identified a causal relationship between the drug and the listed risk."

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA